Home › Funds › Principal Global Investors › PTGX
Principal Global Investors position in PTGX
PROTAGONIST THERAPEUTICS INC · Health Care
Latest position (Q2 2026)385.26K sh
Reported value held$47.23M
Portfolio Weight0.02%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 7.61K | $260.00K | New |
| Q3 2022 | 10.35K | $87.00K | New |
| Q4 2022 | 11.74K | $128.06K | Add |
| Q1 2023 | 13.52K | $311.03K | Add |
| Q2 2023 | 13.90K | $384.00K | Add |
| Q3 2023 | 14.97K | $249.72K | Add |
| Q4 2023 | 14.43K | $330.86K | Reduce |
| Q1 2024 | 14.37K | $415.69K | Hold |
| Q2 2024 | 10.03K | $347.47K | Reduce |
| Q4 2024 | 337.81K | $13.04M | New |
| Q1 2025 | 347.10K | $16.79M | Add |
| Q2 2025 | 330.13K | $18.25M | Reduce |
| Q3 2025 | 326.09K | $21.66M | Reduce |
| Q4 2025 | 347.93K | $30.39M | Add |
| Q1 2026 | 367.82K | $38.77M | Add |
| Q2 2026 | 385.26K | $47.23M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PTGX
- BlackRock Inc 10.31M sh · $1.26B · Q2 2026
- Farallon Capital Management 6.35M sh · $778.25M · Q2 2026
- Vanguard Group 5.41M sh · $472.83M · Q4 2025
- Wellington Management Group 3.42M sh · $418.83M · Q2 2026
- UBS Group AG 3.40M sh · $416.68M · Q2 2026
- Janus Henderson Group 2.89M sh · $304.87M · Q1 2026
- Invesco Ltd 2.34M sh · $286.92M · Q2 2026
- Geode Capital Management 1.74M sh · $213.48M · Q2 2026
- Bank of America Corp 1.32M sh · $162.36M · Q2 2026
- Morgan Stanley 905.99K sh · $111.06M · Q2 2026
- Goldman Sachs Group 812.85K sh · $99.64M · Q2 2026
- Fidelity Management & Research (FMR) 672.19K sh · $82.40M · Q2 2026